We submit herewith statement of deviation or variation in utilization of funds for the half-year/year ended on 31st March, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Cryogenic OGS Limited has filed its half-yearly statement of deviation under SEBI LODR Regulation 32 for the period ending 31st March 2026. The company raised Rs. 17.76 crores via IPO on 10th July 2025. The statement confirms there is NO deviation or variation in the utilization of IPO funds. Funds are being deployed as per the original objects: Working Capital (Rs. 1150 Lakhs allocated, Rs. 240.12 Lakhs utilized), General Corporate Purpose (Rs. 396.47 Lakhs allocated, Rs. 284.31 Lakhs utilized), and Issue Expenses (Rs. 230.13 Lakhs allocated, Rs. 228.29 Lakhs utilized). The audit committee reviewed the statement on 30th April 2026 with no comments.
Positive signal for shareholders — the company is utilizing IPO proceeds as planned with no deviations, indicating proper fund deployment and compliance with stated objectives.